| Literature DB >> 36262897 |
Meghan Brown1, Nika Z Garbajs1, Simon Zec1, Hisham Mushtaq2, Anwar Khedr2, Abbas B Jama2, Ibtisam Rauf3, Mikael Mir4, Aishwarya R Korsapati5, Shikha Jain6, Thoyaja Koritala2, Ramesh Adhikari7, Amos Lal1, Ognjen Gajic1, Juan Pablo Domecq1, Sarah Goksoy8, Brian Bartlett2, Amit Sharma9, Nitesh Kumar Jain2, Syed Anjum Khan2.
Abstract
Multisystem inflammatory syndrome is a life-threatening condition associated with elevated inflammatory markers and multiple organ injury. A diagnosis of exclusion, it has been reported after severe acute respiratory syndrome coronavirus 2 infection (SARS-CoV-2) in children and adults; recently it has been described in some post-COVID-19 vaccinated individuals. The prognosis with supportive care and immunomodulatory therapy is good, although some individuals may require treatment in the intensive care unit (ICU). Here we report a case of a 58-year-old man who developed multi-organ failure after receiving the second dose of the Moderna mRNA-1273 COVID-19 vaccine. He required critical organ support in the ICU. An extensive workup was done to rule out alternative infectious and inflammatory processes. Following a period of gradual in-hospital convalescence, our patient made a full recovery. To our knowledge, this is the first comprehensively described case of multisystem inflammatory syndrome associated with Moderna mRNA-1273 COVID-19 vaccine in an adult over 50 years of age.Entities:
Keywords: Acute tubular necrosis (ATN); COVID-19 vaccine; Immunological products and vaccines; Intensive care; Multisystem inflammatory syndrome in adults (MIS-A); Multisystem inflammatory syndrome in vaccinated individuals (MIS-V); Unwanted effects/Adverse reactions; Vaccination/immunization
Year: 2022 PMID: 36262897 PMCID: PMC9533789 DOI: 10.55729/2000-9666.1087
Source DB: PubMed Journal: J Community Hosp Intern Med Perspect ISSN: 2000-9666